ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population.

The polygenic concept of breast cancer susceptibility calls for the identification of genetic variants that contribute to breast cancer risk. Reduced DNA repair proficiencies in women with breast cancer pointed to a possible role of DNA repair enzymes in the risk to develop the disease. The nucleotide excision repair enzyme encoded by the excision repair cross-complementing group 2 gene ERCC2 (formerly XPD) known to cause skin cancer by germ line mutations has multiple regulatory cellular functions, including nucleotide excision repair, basal transcription, cell cycle control, and apoptosis. ERCC2 polymorphisms ERCC2_6540_G>A (Asp(312)Asn) and ERCC2_18880_A>C (Lys(751)Gln) within the coding region of this evolutionarily highly conserved gene have been of functional relevance and therefore are potential candidates to confer breast cancer susceptibility. Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, we analyzed genotype frequencies in constitutional DNA of study participants of a German case-control study that included 688 cases of incident breast cancer and 724 population-based, age-matched controls. We identified ERCC2_6540_GG (Asp(312)Asp) as an at-risk genotype [odds ratio (OR), 2.06; 95% confidence interval (95% CI), 1.39-3.07]. The ERCC2_6540_GG-associated breast cancer risk was even higher in women who were also carriers of the ERCC2_18880_CC (Gln(751)Gln) genotype (OR, 3.69; 95% CI, 1.76-7.74). We identified ERCC2_6540_G/ERCC2_18880_C (Asp(312)/Gln(751)) as the most potent risk-conferring haplotype (OR, 3.49; 95% CI, 2.30-5.28). To our knowledge, this is the first study assigning breast cancer risk to both the ERCC2 genotype encoding Asp(312)Asp and the haplotype encoding Asp(312)/Gln(751).

[1]  Douglas F. Easton,et al.  Polygenic susceptibility to breast cancer and implications for prevention , 2002, Nature Genetics.

[2]  U. Vogel,et al.  Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited. , 2001, Carcinogenesis.

[3]  A. Harris,et al.  A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. , 2000, Cancer research.

[4]  R. Parshad,et al.  XPD polymorphisms: effects on DNA repair proficiency. , 2000, Carcinogenesis.

[5]  D. Christiani,et al.  Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. , 2002, Cancer research.

[6]  Peter Donnelly,et al.  A comparison of bayesian methods for haplotype reconstruction from population genotype data. , 2003, American journal of human genetics.

[7]  C I Amos,et al.  Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. , 2001, Cancer research.

[8]  C. Harris,et al.  The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. , 1996, Genes & development.

[9]  A. Piazza,et al.  DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case‐control study , 2001, International journal of cancer.

[10]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[11]  Jack A. Taylor,et al.  XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[12]  K. Hemminki,et al.  The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. , 2002, Carcinogenesis.

[13]  E. Bowman,et al.  Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp/Asp genotype. , 2001, Cancer research.

[14]  S. London,et al.  No association between the XPD (Lys751G1n) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  R. Camplejohn,et al.  P53, apoptosis, and breast cancer , 1996, Journal of Mammary Gland Biology and Neoplasia.

[16]  D. Christiani,et al.  Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  C. Ulrich,et al.  Polymorphisms in DNA repair genes and associations with cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  C. Rodolfo,et al.  Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH , 1998, Nature Genetics.

[19]  J. Hoeijmakers,et al.  Molecular genetics of eukaryotic DNA excision repair. , 1990, Cancer cells.

[20]  K. Kelsey,et al.  Associations between ERCC2 polymorphisms and gliomas. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[21]  N. Davidson,et al.  Apoptosis and Breast Cancer , 1999 .

[22]  R. Parshad,et al.  DNA repair proficiency: potential susceptiblity factor for breast cancer. , 1994, Journal of the National Cancer Institute.

[23]  M. Spitz,et al.  XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. , 2000, Carcinogenesis.

[24]  C. Harris,et al.  Genetic polymorphisms in DNA repair genes and risk of lung cancer. , 2001, Carcinogenesis.

[25]  S. Benhamou,et al.  ERCC2/XPD gene polymorphisms and cancer risk. , 2002, Mutagenesis.

[26]  U. Vogel,et al.  Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. , 2004, Mutation research.

[27]  F. Perera,et al.  Polymorphisms in the DNA Repair Enzyme XPD are Associated with Increased Levels of PAH–DNA Adducts in a Case-Control Study of Breast Cancer , 2002, Breast Cancer Research and Treatment.

[28]  Matthew B Schabath,et al.  An Evolutionary Perspective on Single-Nucleotide Polymorphism Screening in Molecular Cancer Epidemiology , 2004, Cancer Research.

[29]  J. Hoeijmakers,et al.  Different removal of ultraviolet photoproducts in genetically related xeroderma pigmentosum and trichothiodystrophy diseases. , 1995, Cancer research.

[30]  Daehee Kang,et al.  Genetic polymorphisms and cancer susceptibility of breast cancer in Korean women. , 2003, Journal of biochemistry and molecular biology.

[31]  J. Hoeijmakers Human nucleotide excision repair syndromes: molecular clues to unexpected intricacies. , 1994, European journal of cancer.

[32]  X. Wang,et al.  Drug-induced apoptosis is delayed and reduced in XPD lymphoblastoid cell lines: possible role of TFIIH in p53-mediated apoptotic cell death , 1999, Oncogene.

[33]  J. Park,et al.  Lys751Gln polymorphism in the DNA repair gene XPD and risk of primary lung cancer. , 2002, Lung cancer.

[34]  P Vineis,et al.  XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. , 2001, Carcinogenesis.

[35]  J. Witte,et al.  DNA Repair Gene XRCC1 and XPD Polymorphisms and Risk of Prostate Cancer , 2004, Cancer Epidemiology Biomarkers & Prevention.